Testing effectiveness (Phase 2)Study completedNCT01920555
What this trial is testing
Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
Who this might be right for
Treatment Resistant Depression
Massachusetts General Hospital 99